Topic: anti-inlammatory

Celebrex May Reduce Skin Cancer

A twice-daily dose of  Celebrex over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according a new study. Read on..SID: COX-2 Inhibitors May Cut Skin Cancer Rate

Insurers Reject Prescriptions To Save Money.

Follow the story of  Tracey who's insurer would not pay for her Celebrex prescription. Read on... Who's the Doctor?